Literature DB >> 17884990

Expression and biological activity of ABCA1 in alveolar epithelial cells.

Sandra R Bates1, Jian-Qin Tao, Kevin J Yu, Zea Borok, Edward D Crandall, Heidi L Collins, George H Rothblat.   

Abstract

The mechanisms used by alveolar type I pneumocytes for maintenance of the lipid homeostasis necessary to sustain these large squamous cells are unknown. The processes may involve the ATP-binding cassette transporter A1 (ABCA1), a transport protein shown to be crucial in apolipoprotein A-I (apoA-I)-mediated mobilization of cellular cholesterol and phospholipid. Immunohistochemical data demonstrated the presence of ABCA1 in lung type I and type II cells and in cultured pneumocytes. Type II cells isolated from rat lungs and cultured for 5 days in 10% serum trans-differentiated toward cells with a type I-like phenotype which reacted with the type I cell-specific monoclonal antibody VIIIB2. Upon incubation of the type I-like pneumocytes with agents that up-regulate the ABCA1 gene (9-cis-retinoic acid [9cRA] and 22-hydroxycholesterol [22-OH, 9cRA/22-OH]), ABCA1 protein levels were enhanced to maximum levels after 8 to 16 hours and remained elevated for 24 hours. In the presence of apoA-I and 9cRA/22-OH, efflux of radioactive phospholipid and cholesterol from pneumocytes was stimulated 3- to 20-fold, respectively, over controls. Lipid efflux was inhibited by Probucol. Sucrose density gradient analysis of the media from stimulated cells incubated with apoA-I identified heterogeneous lipid particles that isolated at a density between 1.063 and 1.210 g/ml, with low or high apoA-I content. Thus, pneumocytes with markers for the type I phenotype contained functional ABCA1 protein, released lipid to apoA-I protein, and were capable of producing particles resembling nascent high-density lipoprotein, indicating an important role for ABCA1 in the maintenance of lung lipid homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884990      PMCID: PMC2258448          DOI: 10.1165/rcmb.2007-0020OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  60 in total

1.  Na transport proteins are expressed by rat alveolar epithelial type I cells.

Authors:  Zea Borok; Janice M Liebler; Richard L Lubman; Martha J Foster; Beiyun Zhou; Xian Li; Stephanie M Zabski; Kwang-Jin Kim; Edward D Crandall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-04       Impact factor: 5.464

2.  Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis.

Authors:  Meshell D Johnson; Jonathan H Widdicombe; Lennell Allen; Pascal Barbry; Leland G Dobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

3.  Rapid quantification of human ABCA1 mRNA in various cell types and tissues by real-time reverse transcription-PCR.

Authors:  D Kielar; W Dietmaier; T Langmann; C Aslanidis; M Probst; M Naruszewicz; G Schmitz
Journal:  Clin Chem       Date:  2001-12       Impact factor: 8.327

4.  Recovery of rat type II cell surfactant components during primary cell culture.

Authors:  Sandra R Bates; Linda W Gonzales; Jian-Qin Tao; Peter Rueckert; Philip L Ballard; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-02       Impact factor: 5.464

5.  TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: tnf-alpha induces TGF-beta(1).

Authors:  G S Warshamana; M Corti; A R Brody
Journal:  Exp Mol Pathol       Date:  2001-08       Impact factor: 3.362

6.  Differential regulation of apolipoprotein A-I/ATP binding cassette transporter A1-mediated cholesterol and phospholipid release.

Authors:  Yoshio Yamauchi; Sumiko Abe-Dohmae; Shinji Yokoyama
Journal:  Biochim Biophys Acta       Date:  2002-11-08

7.  Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3.

Authors:  Surafel Mulugeta; Joseph M Gray; Kathleen L Notarfrancesco; Linda W Gonzales; Michael Koval; Sheldon I Feinstein; Philip L Ballard; Aron B Fisher; Henry Shuman
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

8.  ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux.

Authors:  Nan Wang; Debin Lan; Marie Gerbod-Giannone; Patrick Linsel-Nitschke; Andreas Werner Jehle; Wengen Chen; Laurent O Martinez; Alan R Tall
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

9.  Effect of surfactant protein A on granular pneumocyte surfactant secretion in vitro.

Authors:  Sandra R Bates; Jian-Qin Tao; Kathleen Notarfrancesco; Kristine DeBolt; Henry Shuman; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-07-25       Impact factor: 5.464

Review 10.  ATP-binding cassette transporter A1 and cholesterol trafficking.

Authors:  John F Oram
Journal:  Curr Opin Lipidol       Date:  2002-08       Impact factor: 4.776

View more
  18 in total

1.  Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis.

Authors:  Yoshihisa Nukui; Yasunari Miyazaki; Kozo Suhara; Tsukasa Okamoto; Haruhiko Furusawa; Naohiko Inase
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Lycopene Inhibits Smoke-Induced Chronic Obstructive Pulmonary Disease and Lung Carcinogenesis by Modulating Reverse Cholesterol Transport in Ferrets.

Authors:  Jelena Mustra Rakic; Chun Liu; Sudipta Veeramachaneni; Dayong Wu; Ligi Paul; C-Y Oliver Chen; Lynne M Ausman; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2019-06-08

Review 3.  The A's Have It: Developing Apolipoprotein A-I Mimetic Peptides Into a Novel Treatment for Asthma.

Authors:  Xianglan Yao; Elizabeth M Gordon; Amisha V Barochia; Alan T Remaley; Stewart J Levine
Journal:  Chest       Date:  2016-06-18       Impact factor: 9.410

4.  Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis.

Authors:  Alan N Hunt; Anagha Malur; Tual Monfort; Pavlos Lagoudakis; Sumeet Mahajan; Anthony D Postle; Mary Jane Thomassen
Journal:  Am J Respir Cell Mol Biol       Date:  2017-10       Impact factor: 6.914

5.  5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma.

Authors:  Xianglan Yao; Cuilian Dai; Karin Fredriksson; Pradeep K Dagur; J Philip McCoy; Xuan Qu; Zu-Xi Yu; Karen J Keeran; Gayle J Zywicke; Marcelo J A Amar; Alan T Remaley; Stewart J Levine
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

6.  Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis.

Authors:  Jing Chen; Xiaolu Zhang; Handojo Kusumo; Lucio G Costa; Marina Guizzetti
Journal:  Biochim Biophys Acta       Date:  2012-09-23

7.  ATP-binding cassette transporter 1 attenuates ovalbumin-induced neutrophilic airway inflammation.

Authors:  Cuilian Dai; Xianglan Yao; Boris Vaisman; Todd Brenner; Katharine S Meyer; Meixia Gao; Karen J Keeran; Gayle Z Nugent; Xuan Qu; Zu-Xi Yu; Pradeep K Dagur; J Philip McCoy; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 8.  Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.

Authors:  Xianglan Yao; Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

9.  Apolipoprotein A-I, A-II, and H mRNA and protein accumulation sites in the developing lung in late gestation.

Authors:  Mélissa Côté; Pierre R Provost; Yves Tremblay
Journal:  BMC Res Notes       Date:  2011-07-14

Review 10.  Choline in cystic fibrosis: relations to pancreas insufficiency, enterohepatic cycle, PEMT and intestinal microbiota.

Authors:  Wolfgang Bernhard
Journal:  Eur J Nutr       Date:  2020-08-14       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.